venlafaxine hydrochloride has been researched along with zopiclone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sicot, R | 1 |
Barrera-Groba, C; Hillyard, SG; Tighe, R | 1 |
Fang, L; Guo, X; Jiang, Z; Yu, J | 1 |
Hahn, M; Roll, SC | 1 |
4 other study(ies) available for venlafaxine hydrochloride and zopiclone
Article | Year |
---|---|
[Love, humor and psychosis in an atypical depression].
Topics: Antidepressive Agents; Antipsychotic Agents; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Love; Olanzapine; Piperazines; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Wit and Humor as Topic | 2005 |
Intralipid reverses coma associated with zopiclone and venlafaxine overdose.
Topics: Antidepressive Agents, Second-Generation; Azabicyclo Compounds; Coma; Cyclohexanols; Drug Overdose; Fat Emulsions, Intravenous; Humans; Hypnotics and Sedatives; Male; Middle Aged; Piperazines; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Preparation of a β-Cyclodextrin-Based Open-Tubular Capillary Electrochromatography Column and Application for Enantioseparations of Ten Basic Drugs.
Topics: Azabicyclo Compounds; beta-Cyclodextrins; Brompheniramine; Capillary Electrochromatography; Carbazoles; Carvedilol; Chemistry Techniques, Analytical; Cyclobutanes; Cyclodextrins; Metal Nanoparticles; Microscopy, Electron, Transmission; Piperazines; Propanolamines; Stereoisomerism; Terbutaline; Tropanes; Venlafaxine Hydrochloride | 2016 |
A patient with acute mania after discontinuation of lithium.
Topics: Azabicyclo Compounds; Bipolar Disorder; Drug Interactions; Drug Substitution; Drug Therapy, Combination; Emergency Services, Psychiatric; Humans; Lithium Carbonate; Male; Medication Adherence; Patient Admission; Piperazines; Risk Factors; Substance Withdrawal Syndrome; Thyroxine; Venlafaxine Hydrochloride | 2016 |